公佈重組預案 ST亞星(600319.SH)復牌一字漲停
格隆匯1月14日丨12月27日以後開始停牌,昨晚拋出重組預案的ST亞星(600319.SH)今日復牌一字漲停,報4.86元,漲停封單超26萬手,暫成交13.95萬元,最新總市值15.34億元。公司昨晚公告稱,擬以資產置換和發行股份“同步走”的方式,注入宏濟堂和科源製藥各100%股權。由此,ST亞星有望藉此利落“轉身”成為一家制藥企業。此次交易擬置入資產和擬置出資產的交易價格尚未最終確定,但方案中明確,二者的差額將由上市公司以發行股份的方式,向上述兩家標的公司的全體股東購買。與此同時,上市公司擬向神州姜窖發行股份募集配套資金,募資扣除相關費用後,將全部用於補充流動資金。交易完成以後,宏濟堂和科源製藥將成為ST亞星的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.